Literature DB >> 8206874

Different distributions of glycosphingolipids in mouse and rabbit skeletal muscle demonstrated by biochemical and immunohistological analyses.

J Müthing1, U Maurer, K Sostarić, U Neumann, H Brandt, S Duvar, J Peter-Katalinić, S Weber-Schürholz.   

Abstract

The expression of neutral glycosphingolipids and gangliosides was investigated in mouse and rabbit skeletal muscle by means of biochemical and immunochemical techniques. Neutral glycosphingolipids from muscle of the inbred rabbit strain used in this study showed a simple TLC pattern, comprising mainly monohexosylceramide. In addition to this compound, lactosylceramide, lacto-N-neotetraosylceramide, globoside and Forssman GSL were detected in mouse muscle. The major ganglioside in both species was GM3; GM3 (Neu5Ac) and GM3(Neu5Gc) were found in a 3:1 ratio in mouse muscle, whereas the absence of GM3(Neu5Gc) is characteristic of rabbit muscle. As a general structural feature of all muscle GM3 gangliosides investigated, a C18 fatty acid and C18 sphingosine were the major components besides minor C22 and C24:1 fatty acids of the respective ceramide portions, as revealed by positive and negative ion FAB-MS. alpha 2-3 sialylated lacto-N-neotetraosyl-ceramide (sialylparagloboside) was expressed in both species, whereas the alpha 2-6 sialylated isomeric compound was found only in mouse muscle. Minute quantities of ganglio-series GM1, GD1a, GD1b, and GT1b were detected in muscles from both species. Glycosphingolipid expression could be confirmed immunohistochemically by examining transverse and longitudinal cryosections of skeletal muscle samples. The results provide the basis for the investigation of muscle specific glycosphingolipids that might modulate membrane protein functions in muscle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206874     DOI: 10.1093/oxfordjournals.jbchem.a124326

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

1.  Neuronal activity-dependent membrane traffic at the neuromuscular junction.

Authors:  Francisco Javier Miana-Mena; Sylvie Roux; Jean-Claude Benichou; Rosario Osta; Philippe Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

2.  Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.

Authors:  Francisco Toval; Roswitha Schiller; Iris Meisen; Johannes Putze; Ivan U Kouzel; Wenlan Zhang; Helge Karch; Martina Bielaszewska; Michael Mormann; Johannes Müthing; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.

Authors:  Christian H Schweppe; Petra Hoffmann; Jerzy-Roch Nofer; Gottfried Pohlentz; Michael Mormann; Helge Karch; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

Review 4.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

5.  Ganglioside expression in tissues of mice lacking beta2-microglobulin.

Authors:  A Markotić; A Marusić; J Tomac; J Müthing
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

6.  Quantification of sialic acids in red meat by UPLC-FLD using indoxylsialosides as internal standards.

Authors:  Hong L Yao; Louis P Conway; Mao M Wang; Kun Huang; Li Liu; Josef Voglmeir
Journal:  Glycoconj J       Date:  2016-03-11       Impact factor: 2.916

7.  Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.

Authors:  Josefine Betz; Martina Bielaszewska; Andrea Thies; Hans-Ulrich Humpf; Klaus Dreisewerd; Helge Karch; Kwang S Kim; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

8.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

9.  Expression of neutral glycosphingolipids and gangliosides in human skeletal and heart muscle determined by indirect immunofluorescence staining.

Authors:  M Cacić; J Müthing; I Kracun; U Neumann; S Weber-Schürholz
Journal:  Glycoconj J       Date:  1994-10       Impact factor: 2.916

10.  Immunohistological analyses of neutral glycosphingolipids and gangliosides in normal mouse skeletal muscle and in mice with neuromuscular diseases.

Authors:  M Cacic; K Sostarić; S Weber-Schürholz; J Müthing
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.